ShareHope Medicine Co., Ltd. (TPEX:8403)

ShareHope Medicine Revenue

ShareHope Medicine had revenue of 1.23B TWD in the quarter ending September 30, 2026, with 10.72% growth. This brings the company's total for the last twelve months to 4.61B, up 6.25% year-over-year. In the year 2025, ShareHope Medicine had annual revenue of 4.36B with 0.74% growth. That makes ShareHope Medicine the 20,141st largest company in the world by revenue and 778th in Taiwan.

• Revenue (ttm): 4.61B
• Revenue Growth: +6.25%
• P/S Ratio: 0.55
• Revenue / Employee: 39.11M
• Employees: 118
• Market Cap: 2.52B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medical Circulation Business Development 3.51B 75.5%
• Integrated Management Division 628.60M 13.5%
• Other Department 260.67M 5.6%
• Technological Material Business Segment 129.69M 2.8%
• Hospital Business Segment 124.47M 2.7%

By Geography

Chart

• Asia 4.34B 99.5%
• Other Countries 16.38M 0.4%
• Europe 4.28M 0.1%

Fiscal year ended Dec 31, 2025 See the full ShareHope Medicine breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.36B	32.04M	0.74%
Dec 31, 2024	4.33B	452.45M	11.68%
Dec 31, 2023	3.87B	-263.75M	-6.38%
Dec 31, 2022	4.14B	287.10M	7.46%
Dec 31, 2021	3.85B	-248.85M	-6.07%

Data Source: S&P Global Market Intelligence Last updated: Nov 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error